DEA proposes classifying tianeptine as a Schedule I drug
/ 1 min read
Table of Contents
The Drug Enforcement Administration (DEA) has proposed moving tianeptine into Schedule I of the Controlled Substances Act. This category is reserved for drugs that have a high potential for abuse and no currently accepted medical use in the United States.
Why it matters: This action would change how tianeptine is regulated, moving it from an unregulated substance to one that requires specific federal registration and oversight to handle.
Who it affects
- People who manufacture or distribute tianeptine
This is a proposed rule from the Drug Enforcement Administration; readers should consult the Federal Register for full technical details before taking action.
Agency: Justice Department, Drug Enforcement Administration
Source: Federal Register — read the official document